Home / Anagrelide / United States
US ATC L01XX35 · updated 2 Nov 2026
Anagrelide shortage in United States
Is there an Anagrelide shortage in United States?
Yes. As of 2 Nov 2026, 2 Anagrelide products are reported short in United States, the first since 19 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Spain, Austria. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Nov 2025 | not given | Not stated |
| US | Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).